Complejo Hospitalario Universitario de Pontevedra
Centro asistencial
Hospital San Agustin
Avilés, EspañaPublicaciones en colaboración con investigadores/as de Hospital San Agustin (25)
2024
-
Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?
Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315
2022
2021
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
-
Study of the Diagnostic Delay of Tuberculosis in Spain
Archivos de Bronconeumologia
2020
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
-
Study of the Diagnostic Delay of Tuberculosis in Spain
Archivos de Bronconeumologia
2019
-
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort
Liver International, Vol. 39, Núm. 1, pp. 90-97
2017
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
Respiratory Medicine, Vol. 132, pp. 68-75
-
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme
PLoS ONE, Vol. 12, Núm. 3
-
Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing
Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY
2016
-
Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection
Archivos de Bronconeumologia, Vol. 52, Núm. 9, pp. 477-481
-
Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 304-308
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8
-
Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 303.e1-303.e13
-
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment
Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268
-
Tuberculosis Costs in Spain and Related Factors
Archivos de Bronconeumologia, Vol. 52, Núm. 12, pp. 583-589
2014
-
Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal
Medicine (United States), Vol. 93, Núm. 5, pp. 202-210
2013
-
Corkscrew-like hair and perifollicular purpura as a vitamin C deficiency sign
Medicina Clinica, Vol. 141, Núm. 11
2012
-
A predictive scoring instrument for tuberculosis lost to follow-up outcome
Respiratory Research, Vol. 13